1. M1 Do climate changes influence environmental aspergillus fumigatus load at the manchester university NHS foundation trust adult cystic fibrosis centre?. (12th November 2019) Authors: Coleman, JA; Jones, AM; Collier, LJ; Richardson, MD; Bright-Thomas, RJ Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P102 Sweat chloride is not a useful marker of clinical response to Ivacaftor. (14th November 2013) Authors: Barry, PJ; Flight, WG; Biesty, J; Clough, D; Small, I; Johnson, S; Brennan, AL; Bright-Thomas, RJ; Webb, AK; Jones, AM; Horsley, AR Journal: Thorax Issue: Volume 68(2013)Supplement 3 Page Start: A120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P108 Reclassification of aspergillosis phenotype in adult CF patients & 10 year follow up data. (December 2018) Authors: Collier, LJ; Bright-Thomas, RJ; Denning, D; Richardson, MD; Baxter, C; Jones, AM Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P110 The role of environmental fungus in CF aspergillosis. (December 2018) Authors: Collier, LJ; Bright-Thomas, RJ; Richardson, MD; Jones, AM Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P239 Eradication of new pseudomonas aeruginosa isolates in adults with cystic fibrosis. (12th November 2019) Authors: Boyes, WL; McVean, R; Bright-Thomas, RJ Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P245 Influenza b outbreak at a large adult cf centre: clinical consequences and potential contributing factors. (15th November 2017) Authors: Dennis, JB; Welfare, W; Turner, A; Barry, PJ; Bright-Thomas, RJ Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P247 Lumacaftor/ivacaftor is associated with high discontinuation rates in patients with baseline severe lung function but also benefits in those who tolerate therapy. (15th November 2017) Authors: Wareham, JM; Webb, KA; Jones, AM; Brennan, AL; Bright-Thomas, RJ; Horsley, AR; Barry, PJ Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P251 Environmental fungal sampling in a cystic fibrosis centre. (15th November 2017) Authors: Collier, LJ; Bright-Thomas, RJ; Richardson, M; Jones, AM Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P87 The Impact of Respiratory Viruses and Pulmonary Exacerbations on FEV1 Decline in Adults with Cystic Fibrosis. (19th November 2012) Authors: Flight, WG; Mutton, KJ; Webb, AK; Bright-Thomas, RJ; Jones, AM Journal: Thorax Issue: Volume 67(2012)Supplement 2 Page Start: A101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PTH-145 Comparison Of Percutaneous Endoscopic Gastrostomy, Megestrol Acetate And Nasogastric Feeding In Patients With Cystic Fibrosis. (9th June 2014) Authors: Shabbir, S; Zaidi, M; Mughal, L; Bright-Thomas, RJ; Jones, RB Journal: Gut Issue: Volume 63(2014)Supplement 1 Page Start: A276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗